Click Therapy: Novel Concept in Pretargeting Drug Delivery

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Pharmaceutical Science and Technology, Japan

• Publication date

  2017-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.14843/JPSTJ.77.306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioorthogonal fluorescent labels: a review on combined forces

  2015cited by this paper
• Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics.

  2014cited by this paper
• Abstract 4572: Bioorthogonal, two-component drug delivery in HER2(+) breast cancer mouse models

  2014cited by this paper
• Bioorthogonal reaction pairs enable simultaneous, selective, multi-target imaging.

  2012cited by this paper
• Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways

  2011cited by this paper
• Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection.

  2010cited by this paper
• Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

  2010cited by this paper
• Resistance to Trastuzumab in Breast Cancer

  2009cited by this paper
• A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules

  2005cited by this paper
• Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.

  2004cited by this paper
• Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

  2001cited by this paper
• Click Chemistry: Diverse Chemical Function from a Few Good Reactions.

  2001cited by this paper
• Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.

  1999cited by this paper

• A click chemistry-based, free radical-initiated delivery system for the capture and release of payloads

  2023cites this paper